If you’re going to get hooked on something, it pays to opt for an interest that is intrinsically healthy. And if the “drug” of your choice happens to be a pipeline for your creative abilities, while helping you unload some heavy emotional baggage into the bargain, then you’ve got to be on a winner. All the above, and more, applies succinctly to Dudi Globerman.In fact, it would not be going too far to say that, for the 23-year-old resident of Beitar Illit, getting his thoughts and feelings out of his system and onto a computer screen in visual form and, occasionally, thereafter onto a piece of paper and into a book is akin to a lifesaver – or at least a life quality enhancer.While, in these trying times, the challenges of day-to-day living seem to be continually piling up, Globerman has been dealing with that since the day he was born. He has cystic fibrosis (CF), a genetic disorder that mostly affects the lungs, but also impacts on the pancreas, liver, kidneys and intestine. That can generate any of a host of existential problems, including respiratory difficulties and coughing up mucus as a result of frequent lung infections. It is often a life-threatening condition.WHEN YOU meet Globerman it is a bit hard to believe that his health is so fragile. While short of stature, the young man has impressively broad shoulders and arms and comes across as vital and energized. He smiles a lot, even when discussing some of the more gruesome details of his ongoing health-related saga.He certainly radiates a sense of well-being and positive vibes when he talks about his artistic pursuit. “I have always drawn, since I was very young,” he notes. Presumably, I venture, that helps him to vent some of the frustration and negative emotions brought on by the serious nature of his ailment. “Ever since I was a little boy, drawing has been something that made me stronger and it saved me from all sorts of sticky situations.”There have been plenty of the latter over the years, with Globerman, his devoted parents and his plentiful siblings all chipping in to keep him as well as possible, tackling each crisis as it emerged and doing their best to head new problems off at the pass.Now new hope has come into view for CF sufferers in Israel, in the form of Trikafta, a combination drug approved by the FDA in October 2019. The medicament, which is available to treat patients with the most common cystic fibrosis mutation, is approved for administering to CF patients aged 12 or over who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. This is estimated to represent 90% of the world’s CF population, and includes Globerman. Later this month the Health Ministry is due to make a decision – a potentially life-saving one for Globerman and other Israelis with CF and without substantial financial backing – on whether to include Trikafta in the official ministry medical services basket. Currently, it would cost Globerman the mind-bogglingly prohibitive sum of NIS 1.3 million for each annual dosage of the drug.Naturally, Globerman and his family are keenly awaiting the result of the ministry’s deliberations on the matter.“Most CF patients don’t live past the age of 50,” he says. “Trikafta could extend my life by up to 35 years.” That is, indeed, a big deal and one can only hope, for the artist’s sake, and for others like him, that the drug duly finds its way into the basket before long.GLOBERMAN IS a fighter. He “regales” me with some of the painful and dramatic milestones in his personal continuum to date. But he generally exudes a positive take on the road ahead, and clearly has every intention on living his life to the full. When I park my bicycle out on the Globerman family apartment balcony I espy hefty-looking barbells and other physical exercise facilities, and there is a chin-up bar by the entrance to his room. “I try to use them every day,” he says. “It is very important to me for my physical and spiritual health.” Living out in the Jerusalem Hills, he has quite a view to take in while he’s pumping iron.Globerman’s room is dominated by three computer screens of varying dimensions. There are a couple on his desk, and a bunch of sleek-looking digital screen pens lying around between them. There is also an outsized plasma monitor hanging high up on the wall.